Skip to main content

Table 1 The association of clinicopathological characteristics with results of PDL1 (N=54)

From: Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)

Clinicopathological characteristics

Negative

N (%)

21 (38.9)

Positive

N (%)

33 (61.1)

Significance

Age years

Mean (SD)

52.2 (7.8)

49.8 (10)

t=0.87, p=0.391a

Tumor stage (N=39)

T1/2

3 (30)

7 (70)

p= 1b

T3/4

9 (31)

20 (69)

L.N stage (N=28)

No

6 (40)

9 (60)

p=0.435b

Yes

3 (23.1)

10 (76.9)

M stage (N=36)

No

10 (32.3)

21 (67.7)

p= 1b

Yes

2 (40)

3 (60)

FIGO stage(N=38)

1/2

2 (25)

6 (75)

p= 1b

3/4

10 (33.3)

20 (66.7)

Ascites (N=43)

No

4 (23.5)

13 (76.5)

X2=1.04, p= 0.307

Yes

10 (38.5)

16 (61.5)

Residual tumor (N=39)

No

10 (45.5)

12 (54.5)

X2= 3.33, p=0.068

Yes

3 (17.6)

14 (82.4)

Metastasis (N=39)

No

6 (35.3)

11 (64.7)

X2= 0.29, p=0.59

Yes

6 (27.3)

16 (72.7)

Recurrence (N=38)

No

7 (41.2)

10 (58.8)

X2= 0.66, p=0.415

Yes

6 (28.6)

15 (71.4)

Peritoneal deposits (N= 45)

No

2 (22.2)

7 (77.8)

p= 0.695b

Yes

13 (36.1)

23 (63.9)

Neoadjuvant therapy (N=35)

No

10 (35.7)

18 (64.3)

p=1b

Yes

2 (28.6)

5 (71.4)

Ki-67 (N=53)

Low

11 (52.4)

10 (47.6)

X2=2.367, p=0.124

High

10 (31.2)

22 (68.8)

CEA (N=15)

Median (min-max)

2.8 (0.6–8)

2.1 (0.1–64)

Z=0, p=1c

CA 125 (N=28)

Median (min-max)

273 (170–1230)

298 (7–1268)

Z= −0.92.533, p= 0.360c

  1. aWelch’s t-test
  2. bFisher’s exact test
  3. cMann-Whitney U